← Back to Search

Modified Diabetes Prevention Program for Obesity, Weight Loss, and Prediabetes (DPP-TOO Trial)

N/A
Waitlist Available
Led By Courtney E Gamston, PharmD
Research Sponsored by Auburn University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights
No Placebo-Only Group

Summary

This trial hopes to show that community pharmacies can help with weight loss and diabetes prevention, improving health outcomes.

Eligible Conditions
  • Obesity
  • Prediabetes
  • Weight Loss

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 year for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in A1c
Weight loss
Secondary study objectives
Blood pressure change
Physical activity change
Proportion of patients meeting DPP program criteria
Other study objectives
Change in Processes of Change for Weight Loss including the following processes: emotional re-evaluation, weight consequences evaluation, supporting relationships, and weight management actions
Change in Stage of Change for Weight Loss
Change in level of confidence in ability to motivate oneself to maintain dietary and physical activity behaviors for at least 6 months
+2 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Modified DPPExperimental Treatment1 Intervention
Participants in this arm will participate in the modified Diabetes Prevention Program curriculum.

Find a Location

Who is running the clinical trial?

Auburn UniversityLead Sponsor
79 Previous Clinical Trials
14,559 Total Patients Enrolled
4 Trials studying Obesity
5,930 Patients Enrolled for Obesity
Courtney E Gamston, PharmDPrincipal InvestigatorAuburn University Harrison School of Pharmacy

Media Library

Modified Diabetes Prevention Program Curriculum Clinical Trial Eligibility Overview. Trial Name: NCT05640869 — N/A
Obesity Research Study Groups: Modified DPP
Obesity Clinical Trial 2023: Modified Diabetes Prevention Program Curriculum Highlights & Side Effects. Trial Name: NCT05640869 — N/A
Modified Diabetes Prevention Program Curriculum 2023 Treatment Timeline for Medical Study. Trial Name: NCT05640869 — N/A
~18 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top